205 GENES FOUNDi

Show / hide columns

XML | RDF | TSV | Page of 5 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SKP2S-phase kinase-associated protein 2, E3 ubiquitin protein ligaseCancer-related genes
Predicted intracellular proteins
Nucleus
Cytosol
Renal cancer: 4.77e-15
Melanoma: 3.72e-7
Ovarian cancer: 8.57e-4
Tissue enriched
SIRPGSignal-regulatory protein gammaCD markers
Predicted membrane proteins
Melanoma: 7.36e-7
Endometrial cancer: 1.05e-6
Renal cancer: 1.47e-6
Head and neck cancer: 2.24e-4
Tissue enhanced
PAPSS23'-phosphoadenosine 5'-phosphosulfate synthase 2Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
MitochondriaMelanoma: 1.33e-6
Thyroid cancer: 3.21e-5
Pancreatic cancer: 6.58e-4
Expressed in all
TICRRTOPBP1-interacting checkpoint and replication regulatorPredicted intracellular proteins
NucleoplasmMelanoma: 2.87e-6
Endometrial cancer: 4.44e-4
Mixed
TIMELESSTimeless circadian clockPredicted intracellular proteins
NucleusMelanoma: 1.06e-5
Renal cancer: 2.61e-5
Liver cancer: 3.61e-4
Mixed
MCM6Minichromosome maintenance complex component 6Enzymes
Plasma proteins
Predicted intracellular proteins
NucleoplasmRenal cancer: 8.29e-12
Liver cancer: 5.70e-7
Melanoma: 1.09e-5
Mixed
NUDT15Nudix (nucleoside diphosphate linked moiety X)-type motif 15Enzymes
Predicted intracellular proteins
NucleoplasmMelanoma: 1.25e-5
Expressed in all
MED20Mediator complex subunit 20Predicted intracellular proteins
Predicted secreted proteins
Nucleoplasm
Centrosome
Melanoma: 1.48e-5
Renal cancer: 1.17e-4
Expressed in all
CKS1BCDC28 protein kinase regulatory subunit 1BCancer-related genes
Predicted intracellular proteins
Nucleus
Vesicles
Mitochondria
Cytosol
Renal cancer: 6.03e-7
Liver cancer: 2.94e-5
Melanoma: 3.12e-5
Thyroid cancer: 4.87e-4
Pancreatic cancer: 6.13e-4
Endometrial cancer: 7.89e-4
Expressed in all
CCNB2Cyclin B2Cancer-related genes
Plasma proteins
Predicted intracellular proteins
Transporters
Golgi apparatus
Cytosol
Renal cancer: 0.00e+0
Pancreatic cancer: 1.74e-5
Melanoma: 3.21e-5
Liver cancer: 2.83e-4
Lung cancer: 4.63e-4
Tissue enhanced
ZNF544Zinc finger protein 544Predicted intracellular proteins
Transcription factors
NucleoplasmLiver cancer: 1.04e-5
Melanoma: 3.65e-5
Expressed in all
HLA-GMajor histocompatibility complex, class I, GCancer-related genes
Predicted membrane proteins
Melanoma: 3.91e-5
Tissue enriched
KCTD14Potassium channel tetramerization domain containing 14Predicted intracellular proteins
Melanoma: 3.96e-5
Renal cancer: 6.92e-5
Pancreatic cancer: 1.05e-4
Thyroid cancer: 5.93e-4
Ovarian cancer: 8.01e-4
Mixed
CD2CD2 moleculeCD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 4.82e-6
Endometrial cancer: 1.69e-5
Melanoma: 3.97e-5
Head and neck cancer: 7.46e-5
Cervical cancer: 1.47e-4
Breast cancer: 4.36e-4
Ovarian cancer: 7.72e-4
Tissue enhanced
MCM3Minichromosome maintenance complex component 3Cancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
NucleoplasmThyroid cancer: 3.13e-5
Melanoma: 4.40e-5
Liver cancer: 1.40e-4
Cervical cancer: 1.89e-4
Expressed in all
OTUD7BOTU deubiquitinase 7BEnzymes
Predicted intracellular proteins
Nucleoplasm
Microtubules
Melanoma: 5.09e-5
Endometrial cancer: 7.47e-4
Mixed
LCKLCK proto-oncogene, Src family tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Golgi apparatusEndometrial cancer: 2.96e-6
Renal cancer: 2.60e-5
Melanoma: 5.65e-5
Head and neck cancer: 2.91e-4
Tissue enhanced
MAT2AMethionine adenosyltransferase II, alphaEnzymes
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Cytosol
Endometrial cancer: 5.29e-5
Melanoma: 5.94e-5
Liver cancer: 4.87e-4
Lung cancer: 8.94e-4
Expressed in all
GNLYGranulysinPredicted intracellular proteins
Predicted secreted proteins
Transporters
Endometrial cancer: 3.48e-5
Melanoma: 6.60e-5
Renal cancer: 1.50e-4
Urothelial cancer: 8.07e-4
Tissue enhanced
TDGThymine DNA glycosylaseEnzymes
Predicted intracellular proteins
NucleoplasmRenal cancer: 1.90e-10
Liver cancer: 6.27e-5
Melanoma: 6.90e-5
Expressed in all
CDC5LCell division cycle 5-likeDisease related genes
Plasma proteins
Predicted intracellular proteins
Transcription factors
NucleoplasmMelanoma: 7.02e-5
Expressed in all
PUS7Pseudouridylate synthase 7 (putative)Predicted intracellular proteins
NucleusRenal cancer: 1.03e-8
Liver cancer: 4.89e-6
Melanoma: 7.58e-5
Thyroid cancer: 6.28e-4
Mixed
ZNF551Zinc finger protein 551Predicted intracellular proteins
Transcription factors
Nucleoplasm
Nuclear speckles
Melanoma: 7.68e-5
Renal cancer: 1.32e-4
Mixed
NFKB2Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)Cancer-related genes
Disease related genes
Predicted intracellular proteins
Transcription factors
Nucleoplasm
Cytosol
Renal cancer: 6.69e-12
Melanoma: 8.45e-5
Colorectal cancer: 3.86e-4
Expressed in all
STK38Serine/threonine kinase 38Enzymes
Predicted intracellular proteins
CytosolMelanoma: 9.44e-5
Expressed in all
DLGAP4Discs, large (Drosophila) homolog-associated protein 4Predicted intracellular proteins
Nucleoplasm
Focal adhesion sites
Cytosol
Liver cancer: 3.73e-6
Endometrial cancer: 2.24e-5
Melanoma: 9.88e-5
Renal cancer: 2.48e-4
Expressed in all
SFSWAPSplicing factor, suppressor of white-apricot familyPlasma proteins
Predicted intracellular proteins
Nucleus
Plasma membrane
Cytosol
Renal cancer: 3.33e-8
Melanoma: 1.10e-4
Expressed in all
MARK3MAP/microtubule affinity-regulating kinase 3Enzymes
Predicted intracellular proteins
Predicted membrane proteins
Nuclear membraneMelanoma: 1.14e-4
Expressed in all
MCM4Minichromosome maintenance complex component 4Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
NucleoplasmEndometrial cancer: 2.84e-5
Melanoma: 1.15e-4
Liver cancer: 1.23e-4
Colorectal cancer: 2.19e-4
Pancreatic cancer: 2.38e-4
Renal cancer: 2.61e-4
Expressed in all
TFCP2Transcription factor CP2Predicted intracellular proteins
Transcription factors
Nucleoplasm
Cytosol
Melanoma: 1.18e-4
Liver cancer: 1.83e-4
Expressed in all
STK19Serine/threonine kinase 19Cancer-related genes
Enzymes
Predicted intracellular proteins
Nuclear specklesMelanoma: 1.18e-4
Mixed
CD3ECD3e molecule, epsilon (CD3-TCR complex)CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Endometrial cancer: 2.30e-6
Renal cancer: 1.12e-5
Melanoma: 1.18e-4
Head and neck cancer: 1.32e-4
Cervical cancer: 1.62e-4
Breast cancer: 1.72e-4
Tissue enhanced
KIF3CKinesin family member 3CPlasma proteins
Predicted intracellular proteins
Nuclear membrane
Nuclear bodies
Intermediate filaments
Endometrial cancer: 1.32e-5
Melanoma: 1.22e-4
Renal cancer: 7.57e-4
Tissue enriched
SLAMF6SLAM family member 6CD markers
Predicted membrane proteins
Renal cancer: 2.09e-6
Head and neck cancer: 7.34e-5
Melanoma: 1.25e-4
Cervical cancer: 2.78e-4
Breast cancer: 9.42e-4
Endometrial cancer: 9.53e-4
Tissue enhanced
RCC2Regulator of chromosome condensation 2Predicted intracellular proteins
Liver cancer: 3.42e-8
Renal cancer: 4.03e-8
Melanoma: 1.30e-4
Cervical cancer: 3.31e-4
Mixed
TMEM237Transmembrane protein 237Disease related genes
Predicted membrane proteins
Renal cancer: 7.96e-6
Melanoma: 1.33e-4
Endometrial cancer: 2.51e-4
Mixed
MPPE1Metallophosphoesterase 1Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Golgi apparatus
Renal cancer: 6.45e-7
Melanoma: 1.35e-4
Expressed in all
NR1D1Nuclear receptor subfamily 1, group D, member 1Nuclear receptors
Predicted intracellular proteins
Transcription factors
Nuclear bodiesMelanoma: 1.36e-4
Colorectal cancer: 1.94e-4
Mixed
ZNF587BZinc finger protein 587BPredicted intracellular proteins
NucleusProstate cancer: 1.33e-4
Melanoma: 1.37e-4
Mixed
PNRC2Proline-rich nuclear receptor coactivator 2Predicted intracellular proteins
Nucleoplasm
Golgi apparatus
Liver cancer: 7.97e-5
Melanoma: 1.41e-4
Urothelial cancer: 4.05e-4
Breast cancer: 6.02e-4
Expressed in all
POLEPolymerase (DNA directed), epsilon, catalytic subunitCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleus
Plasma membrane
Renal cancer: 3.19e-8
Melanoma: 1.44e-4
Expressed in all
PLA2G2APhospholipase A2, group IIA (platelets, synovial fluid)Enzymes
FDA approved drug targets
Predicted secreted proteins
RAS pathway related proteins
Nucleus
Nucleoli
Melanoma: 1.49e-4
Tissue enhanced
POLR3CPolymerase (RNA) III (DNA directed) polypeptide C (62kD)Predicted intracellular proteins
RNA polymerase related proteins
NucleoplasmRenal cancer: 1.85e-5
Melanoma: 1.50e-4
Endometrial cancer: 1.56e-4
Liver cancer: 5.48e-4
Expressed in all
ILF3Interleukin enhancer binding factor 3, 90kDaCancer-related genes
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Nucleoli
Mitochondria
Melanoma: 1.57e-4
Renal cancer: 9.65e-4
Expressed in all
ZNF3Zinc finger protein 3Predicted intracellular proteins
Transcription factors
NucleoplasmMelanoma: 1.59e-4
Urothelial cancer: 2.20e-4
Lung cancer: 5.73e-4
Expressed in all
ZNF480Zinc finger protein 480Predicted intracellular proteins
Transcription factors
NucleoplasmMelanoma: 1.65e-4
Renal cancer: 2.03e-4
Mixed
PGBD1PiggyBac transposable element derived 1Predicted intracellular proteins
Nucleoplasm
Cytosol
Melanoma: 1.71e-4
Liver cancer: 3.77e-4
Renal cancer: 4.97e-4
Pancreatic cancer: 6.79e-4
Mixed
C2orf47Chromosome 2 open reading frame 47Predicted intracellular proteins
MitochondriaMelanoma: 1.87e-4
Endometrial cancer: 2.14e-4
Head and neck cancer: 3.81e-4
Expressed in all
SPNSialophorinCD markers
Predicted membrane proteins
Golgi apparatus
Plasma membrane
Cell Junctions
Endometrial cancer: 3.08e-5
Breast cancer: 1.40e-4
Melanoma: 1.88e-4
Tissue enhanced
GSTM3Glutathione S-transferase mu 3 (brain)Cancer-related genes
Enzymes
Predicted intracellular proteins
Nucleoli
Cytosol
Melanoma: 1.89e-4
Expressed in all

Page of 5 | next »